Lv61
1780 积分 2023-09-01 加入
MA02.03 Repotrectinib in Patients With ROS1 Fusion-Positive (ROS1+) NSCLC: Long-Term Follow-Up From the Phase 1/2 TRIDENT-1 Trial
14天前
已关闭
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours
15天前
已完结
Regrowth of Eyebrows in a Previous Steroid Non-Responder With Alopecia Universalis After Ritlecitinib Treatment
17天前
已完结
Regrowth of Eyebrows in a Previous Steroid Non-Responder With Alopecia Universalis After Ritlecitinib Treatment
17天前
已关闭
Ritlecitinib in alopecia areata: A multicenter retrospective real-world analysis
18天前
已完结
Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology
28天前
已完结
Efficacy and safety of taletrectinib for treatment of ROS1 positive non-small cell lung cancer: A systematic review
1个月前
已完结
Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience
1个月前
已完结
Alopecia Areata: Current and Emerging Therapies
1个月前
已完结
Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
1个月前
已完结
皖公网安备34019202002308
